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THE study of enzymes which depolymerise nucleic acids and participate in
transformation of the products at the nucleotide and nucleoside levels has not
yet succeeded in assigning or excluding for these enzymes a function related to
the development ofmalignant properties in the cancer cell. The origin ofexisting
conflict among investigators in this field must be sought in the variety of tech-
niques which have been applied to a diversity of tissues. Only the briefest
account of such work can be given here and must be restricted to those enzymes
ofdirect interest to the present authors.
Ribonucleases (EC 2.7.7.16)
Most tissues contain several enzymes which depolymerise ribonucleic acid
(RNA). These are customarily distinguished by their pH optima and referred to
as alkaline ribonuclease (alk. RNAase) and acid ribonuclease (acid RNAase).
An extensive study of azo dye carcinogenesis in rat liver was carried out by
Allard, de Lamirande and Cantero (1957). These authors reported increased
specific activity of acid RNAase throughout tumour development; the specific
activity of alk. RNAase did not alter during induction, but where tumours were
induced their content of this enzyme was greatly increased. These findings
were in accord with earlier work suggesting increased RNAase activity in hepa-
tomas (Schneider, Hogeboom, Shelton and Striebich, 1953; Maver and Greco,
1956). A later study by Reid and Lotz (1958) did not support these conclusions;
their examination of the effect of azo dye carcinogenesis on rat liver RNAases
led them to make only twogeneralisations-firstly that the level ofneither enzyme
was lowered in the cytoplasm after dye ingestion, and secondly, that acid RNAase
in the supernatant fraction was increased in precancerous liver.
Brody and Balis (1958) compared a small series of animal and human tumours
with homologous normal tissues and found that only in human pancreatic
carcinoma did RNAase activity exceed that of normal tissue. They were unable
to confirm the suggestion ofLedoux that the ratio ofRNAase to RNA was lowered
in tumours (Ledoux, Pileri and Vanderhaeghe, 1958; Ledoux, Brandli and Paepe,
1958). Using a histochemical technique, Daoust and Amano (1963) could detect
no RNAase activity in a large series ofhuman and animal tumours. An extensive
investigation of transplantable rat hepatomas was carried out by Roth, Hilton
and Morris (1964). They described various shifts in the distribution of RNAasesD. M. GOLDBERG AND JANET F. PITTS
among the cell fractions and noted that, with two exceptions, the level ofRNAase
inhibitor in the tumour was lower than that of the surrounding normal liver.
Summarising the position in a review some years ago, Roth (1963) stated that
" scarcely a beginning has been made in our understanding of the relation of
RNAase activity to cancer or even to RNA metabolism in the normal cell ".
Deoxyribonuclease I (EC 3. 1.4.5) (DNAase I)
Although thisenzymeis bestrepresentedinthe exocrine secretionofthe pancreas
similar enzymes are widely distributed in most animal tissues. Until recently
their function was obscure, but the finding of increased DNA synthesis when
DNAase I is added to extracts with DNA polymerase activity points to the
possibility of their reducing native DNA to a size suitable for action as a primer
during DNA synthesis (Mantsavinos and Canellakis, 1959; Sarkar, 1961 ; Keir,
1962). There is good evidence that increased activity ofthe enzyme is one ofthe
earliest phenomena associated with viral growth (Keir and Gold, 1963; Russell,
Gold, Keir, Omura, Watson and Wildy, 1964), but little work has appeared on a
possible relationship of this enzyme to tumour growth.
Deoxyribonuclease II (EC 3. 1.4.6) (DNAase II)
This enzyme is also widely distributed in animal tissues. Many reports have
claimed a relationship between the DNAase II content oftissues and their mitotic
rate (Allfrey and Mirsky, 1952; Goutier and Goutier-Pirotte, 1961 ; Goutier and
Leonard, 1962). Increased activity is also associated with tissue regeneration
(Brody and Thorell, 1957; Brody and Balis, 1959; Goutier-Pirotte and Goutier,
1962). Studies on embryonic development and metamorphosis, on the other
hand, do not suggest that the enzyme participates directly in these processes, its
function more probably being restricted to resorption of nuclear debris (Blumen-
thal, 1957; Coleman, 1963; Solomon, 1964).
The activity of DNAase II in hepatomas and in the pre-cancerous livers of
rats fed azo dyes exceeded that of normal rat liver (Schneider et al., 1953; de
Lamirande, Allard andCantero, 1954). Comparison ofnormaltissues and tumours
ofhuman and animal origin led Brody and Balis (1958) to suggest that the enzyme
has either a synthetic function or a growth-regulating effect. By contrast,
Daoust and Amano (1963) examined a wide range of animal and human tumours
by ahistochemicaltechnique andfoundthatDNAase II activity was much reduced
in malignant cells.
Adenosine deaminase (EC 3.5.4.4) (ADase)
The deamination oftheriboside or deoxyriboside ofadenine is catalysed by this
widely occurring enzyme, the product being the corresponding hypoxanthine
derivative. Increased activity was reported in Novikoff hepatoma transplants
(de Lamirande, Allard and Cantero, 1958) and also during the development of
Flexner-Jobling carcinoma (Fodor, Tomashefsky and Funk, 1958). In contrast
with other purine-catabolising enzymes which fell during azo dye carcinogenesis,
ADase activity per unit weight of liver was reported to be unaltered in the rat
(Reid andLewin, 1957). Subsequentworkhas shown thatADase activity actually
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increases during azo dye carcinogenesis although it is likely that this is related to
dye metabolism rather than to initiation of malignancy (Chan, McCoy and Kizer,
1959; de Lamirande and Allard, 1959b; Fiala and Kasinsky, 1961).
Roth, Sheid and Morris (1963) compared the ability to deaminate deoxy-
adenosine in normal liver and several rat hepatomas but were unable to demon-
strate a consistent change in the tumours. If increased ADase is a characteristic
of tumours, it might be expected to diminish during tumour regression, but two
studies have shown this not to be the case (Waravdekar, Paradis and Leiter, 1955;
Fodor et al., 1958).
In order to examine the behaviour of these enzymes in human malignant
neoplasia, a systematic study of their activity in several types of carcinoma was
commenced in this laboratory. The present communication reports our findings
in carcinoma of the cervix uteri.
MATERIALS AND METHODS
A total of 25 specimens were obtained by curettage from patients with
carcinoma of the cervix uteri; two were adenocarcinomata and the remainder
were squamous carcinomata. Sixteen samples were obtained from patients
undergoing amputation of the cervix uteri for repair of uterine prolapse and were
free of malignant changes; a wedge of tissue was cut to include a large area of
surface epithelium with the minimum of underlying layers. This material will
be regarded as " normal ".
Preparation of cytoplas3mic fractions.-The samples were placed in ice-cold
distilled water, washed free of blood and exudate, dried thoroughly on adsorbent
paper, weighed, and stored at 20° C. After 7-10 days, they were cut on a
freezing microtome into 10-40 micron sections, quantitatively added to a known
volume of ice-cold sucrose 025 M, and homogenised for 3 minutes in an M.S.E.
blendor. Separation of 3 cytoplasmic fractions was achieved with the following
system of centrifugation in the M.S.E. " Superspeed 1700 " refrigerated centrifuge
at 4° C. :
500 x g for 10 min.-pellet discarded
6000 x g for 20 min. pellet termed " mitochondrial fraction
35,000 x g for 60 min.-pellet termed " microsomal fraction"
and unsedimented liquor " supernatant fraction ".
All pellets were washed once with an appropriate volume of ice-cold sucrose and
re-sedimented at the original speed, and all transfers were carried out quantita-
tively.
The mitochondrial and microsomal preparations were dispersed in a known
volume of ice-cold distilled water and subjected under ice to 20 Kc./sec. in the
M.S.E. Ultrasonic Disintegrator Model 60W. In some samples it was not possible
to obtain particulate fractions; in others, the size ofthe fractions did not warrant
separate analysis-instead, they were combined and referred to as " combined
particles ".
Nucleases were estimated on all cytoplasmic fractions according to methods
described for urine by Goldberg, MacVicar and Watts (1966). ADase activity
was measured in the supernatant using the method of Solomon (1960) as modified
for serum by Goldberg (1965).
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Ribonucleases.-0 1 ml. of test material was added to a mixture of 1-9 ml. of
buffer (0.1 M-Tris, pH 7.4 for alk. RNAase and 0-1 m-acetate, pH 5-6 for acid
RNAase) and 1 0 ml. ofyeast nucleic acid (Pabst Laboratories) purified according
to Zytko, de Lamirande, Allard and Cantero (1958) and adjusted to contain 0-5 mg.
phosphorus per ml. After incubation at 370 C. for 30 minutes, 2.0 ml. of 0-75%o
(w/v) uranyl acetate in 4-17 N-perchloric acid (ice-cold) were added and the well-
shaken mixture placed in ice for 30 minutes. It was then filtered (Whatman
No. 42) and the extinction of a 1 in 20 dilution of the filtrate was read at 260 m,t
in a 1 cm. light path against a blank comprising a 1 in 50 dilution of the uranyl
acetate/perchloric acid reagent. Controls for each specimen were run, adding
the uranyl acetate/perchloric acid prior to addition ofthe sample to the buffer/sub-
strate mixture. The extinction of the control was subtracted from that of the
test and the value converted to ,ug. RNA-phosphorus solubilised/hr. by reference
to a calibration curve constructed bydigesting solutions ofknown RNA-phosphorus
content with 4-17 N-perchloric acid at 370 C. until the material was solubilised,
when its extinction at 260 m,u was recorded. For both RNAases, activity was
proportional to concentration provided the value E260test-E260control did not
exceed 0 350. If this occurred, the assay was repeated using a dilution of the
original material.
Deoxyribonucleases.-The buffer/substrate mixture for DNAase I comprised
0-25 ml. salmon sperm DNA (California Corporation for Biochemical Research)
dissolved in 0U005 N-NaOH and adjusted to a phosphorus concentration of 0-3 mg.
per ml., 0.25 ml. of 0-1 M-MgS04, and 0 75 ml. of 0X16 M-Tris buffer, pH 7-5. To
this was added 0-25 ml. of test material, and after incubation for 4 hours at 370 C.
the reaction was stopped by addition of 0.4 ml. of 3.6 M-trichloroacetic acid (ice-
cold). After standing in ice 30 minutes, the precipitate was spun down at
3000 x g for 15 minutes. The supernatant was diluted 1 in 20 and its extinction
at 260 m,u and at 290 m,t in a 1 cm. light path read against distilled water. A
control for each specimen was processed identically, except that the sample was
added after the precipitant at the end of the incubation period. For each assay
the value
(E260-E290)test - (E260-E290)control
was calculated and converted to ,ug. DNA-phosphorus solubilised/hour by reference
to a calibration curve constructed by digesting substrate solutions of known
phosphorus content with trichloroacetic acid at 37° C. and reading the extinction
of the solubilised material at 260 m,u and at 290 mut.
The buffer/substrate mixture for DNAase II comprised 0.25 ml. salmon sperm
DNA standardised as above, 0-25 ml. of 10% (w/v) disodium ethylene-diamino-
tetraacetate dihydrate, and 0 75 ml. of 0-2 M-acetate buffer, pH 5-6. In every
other respect, the procedure was identical to that for DNAase I. Both enzymes
were linear with respect to concentration up to a value for
(E260-E290)test - (E260-E290)control
of 0*200. Where this was exceeded, the assay was repeated on a dilution of the
original specimen.
Adenosine, deaminase.-The extinction of a solution containing 20 aug. per ml.
of 0-1 M-phosphate buffer, pH 7.0, was read at 265 mu in a 1 cm. light path
immediately after addition of test material (0.05 ml./3.0 ml. buffer-substrate
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mixture) and again after incubation at 370 C. for one hour, the spectrophotometer
being set at zero using 0-05 ml. oftest material in 3*0 ml. of0.1 M-phosphate buffer,
pH 7 0, as a control incubated in parallel with the test solution. The fall in
extinction due to deamination of adenosine was converted to ,aM substrate
deaminated/hr. by applying a factor derived from measurement of the E265 of
that amount of inosine theoretically produced by complete deamination of the
substrate. By this technique, the fall in E265 was proportional to amount of
enzyme added when the former did not exceed 0-250. Where this occurred, the
estimation was repeated using a dilution ofthe original material. As this method
may be used only with clear solutions, the assay was confined to the supernatant
fraction of cervical specimens.
Protein.-This was estimated in all fractions using the method of Lowry,
Rosebrough, Farr and Randall (1951).
RESULTS
Separation of mitochondrial and microsomal fractions was accomplished in
18 cancer specimens. Five samples were too small for collection of particle
fractions, but in another two the pooled fractions were adequate for analysis.
Problems were encountered with normal samples. Their higher collagen
content made it difficult to obtain a line of demarcation after the first centrifuga-
tion at 500 g; straining the homogenate through muslin was only partially
successful. Although cytoplasmic particles were probably lost during these
early stages, it seemed from the clarity ofthe 500 g supernatant that the specimens
were intrinsically poor in particles. This made it impossible to collect mito-
chondria and microsomes as discrete fractions from all but three of the samples;
pooled fractions were obtained from a further four.
The data for mitochondrial and microsomal fractions of the carcinomata are
presented in Table I. No significant differences between the two were found.
Suclh was also the case with the discrete fractions obtained from the three normal
specimens. Accordingly, in all cases where mitochondrial and microsomal
fractions had been collected, the enzyme activities were added and divided by the
sum of the protein content ofthe two fractions, so that comparison could be made
betw-een the combined particles of normal and malignant cervix.
TABLE I.-Nuclease Activities of Mitochondrial and Microsomal
Fractions of Malignant Cervix Uteri
Mean±S.E. of 18 samples. Activities as defined in legend for Table II.
Per cent
Units/mg. protein Units/g. wet weight cytoplasmic activiy
r A, r -
Mitochondria Microsomes MIitochondria Microsomes MNitochondria Mlicrosomes
Alk. RN'Aase 509-0-4-80-2 485-6±67-6 3-840-55 4-21±0-59 11-9±0-7 12-1±0-9
Acid RNAase 298-4±48-3 286-7±442 2-16±0-35 2 55±0 39 13-74-1-4 14- 1±0 9
DNAase I 1-71±0-55 1-71±0-31 12-7±3-7 17-231 14-5±2-4 20-6±3-7
DNAaseII 4-48±0-67 4-76±0-74 33-9±5-2 47-6±8-3 . 6-5±0-7 8-1±1-0
Alk. RNAase
There was virtually a complete separation ofthe normal from the cancer group
when the activity of this enzyme in the supernatant was measured relative to
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weight orto protein content ofthe specimens (Fig. 1 and 2, TableII). The activity
of one normal exceeded that of the lowest cancer. The same situation applied
when cytoplasmic particles were compared (Table III). Although the bulk ofthe
cytoplasmic enzyme was located in the supernatant in both groups, the difference
between the normals (92.8%) and the carcinomata (76 2%) was highly significant.
Acid RNase
As with the previous enzyme, the activity of this enzyme in the supernatant
of the cancer group was fifteen-fold that of the normals relative to protein and
twenty-fold relative to tissue weight; indeed the two groups were entirely
separable by the latter criterion (Fig. 1 and 2, Table II). These differences were
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FIG. 1.-Enzyme activities of supernatant fraction in relation to protein concentration in
individual samples of non-malignant (solid circles) and malignant (open circles) human
cervix uteri. Abbreviations as in text.
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reflected in the comparative acid RNAase content of the cytoplasmic particles of
the two groups (Table III). Once again, the bulk ofthe cytoplasmic enzyme was
located in the supernatant though the difference between the normals (89 8%) and
the carcinomata (72-4%) was very significant.
DNAase I
Althoughthe meanactivity ofthisenzymerelative toproteininthesupernatant
fraction of the carcinomata was almost three-fold that of the normals, this differ-
ence was only just significant (P < 0.05) and the two groups overlapped to a
considerable extent (Fig. 1). The difference between the groups was enhanced
when activity was related to tissue weight (Fig. 2) and was then highly significant
mgRNA-P/hr/g. mgRNA-P/hrIg. AgDNA-PIhrig.A&gDNA-PIhrig.
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FIG. 2.-Enzyme activities of supernatant fraction in relation to tissue weight in individual
samples of non-malignant (solid circles) and malignant (open circles) human cervix uteri.
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(P < 0.001). UJnlike the two previous enzymes, the specific activities of the
particles were similar in both groups, although relative to tissue weight the
carcinomata had a higher content of particle-bound DNAase I (Table III). In
both groups, less of the cytoplasmic DNAase I was located in the supernatant
than was the case with alk. and acid RNAase.
DNAaase II
The two groups were more clearly separable with respect to DNAase II activity
than was possible with the previous enzyme. In the supernatant, the lowest
specific activity in the carcinoma series was exceeded by only four normals,
while only three surpassed the lowest activity per g. wet weight observed in the
cancer group. The DNAase activity of cytoplasmic particles from cancer tissue
was very much higher than that ofthe corresponding material from normal tissue.
In both groups, the bulk of the enzyme was present in the supernatant, but the
percentage which was particle bound was greater in the carcinomata and this
difference was very significant.
ADa8e
The activity of this enzyme in the supernatant of the cancer tissues was
significantly higher thanthat ofthe normals. While considerable overlap between
the groups was apparent when activity was related to protein, only four cancer
specimens fell within the range obtained for normals when activity was related to
tissue weight.
Protein content
The relevant data are presented in Table IV and show that per unit of wet
weight the cytoplasmic content of protein was greater in cervical carcinomata
than in normal cervix (for supernatant fractions, t = 2.03, P < 0*05; for particle
fractions, t = 4.95, P < 0.001). More ofthis protein seemed to be present in the
particles of the cancer tissue-24-8%, compared with 5*7% in the normals (t =
6*45, P < 0.001). The particulate protein was fairly evenly distributed between
the mitochondrial and microsomal fractions in the cancers, and in the three
normals where such data were obtained.
Enzyme activity and malignancy
An attempt was made to correlate the enzyme content of the cancers with
their malignancy. For this purpose the carcinomata were divided into the
following groups:
(a) Highly malignant (severe).-All cases classified clinically as Stage III were
placed in this category together with those classified as Stage II but in which
histological examination indicated a high degree ofmalignancy according to three
criteria: degree of differentiation, mitotic rate, and invasiveness. Eleven cases
satisfied these criteria.
(b) Moderately malignant (moderate).-The single Stage I case, together with
those Stage II cases in which the lesion was reported to be well-differentiated,
with low invasiveness and low mitotic rate, were placed in this group, making six
cases in all.
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(c) Intermrediate.-This group comprised eight cases who could not be placed
in either ofthe above categories. A clear-cut evaluation ofthe malignant process
was not possible because ofambiguous histological features, or because ofsecondary
pathological changes such as necrosis, inflammatory infiltration or stromal reaction.
The mean results in all three groups are presented in Table V. The most
obvious feature was the lack of correlation between the degree of malignancy
implied in the classification and the enzyme content of the samples. Only with
respect to DNAase II content could the groups be arranged in an order corres-
ponding with their suspected malignancy.
TABLE V.-Enzyme Activities in Supernatant Fraction of Malignant
Cervix Uteri Graded According to Degree of Malignancy
Cases divided into Severe (11), Intermediate (8) and Moderate (6) according
to criteria given in text. Activities as defined in legend to Table II.
Activity/mg. protein Activity/g. wet weight
Severe Intermediate Moderate Severe Intermediate Moderate
Alk. RNAase 514-8 602-6 497-3 230 21-0 17-7
Acid RNAase 257-4 269- 1 310-0 . 110 9 8 11.1
DNAase I . 0 93 1-69 1-06 . 42-6 61-3 41-2
DNAase II 10-65 8-02 6-48 . 498 373 274
ADase 1306 1469 731 51-1 57 2 27- 7
DISCUSSION
The nature of the enzyme activity
The purpose ofthe present work was to measure the net activity ofthe enzymes
studied in normal and cancerous cervix uteri. Natural inhibitors of RNAases
(Roth, 1956; Shortman, 1961; Roth, 1962) and of DNAases (Henstell and
Freedman, 1952; Festy and Paoletti, 1963; Loiselle and Carrier, 1963; Lindberg,
1964) seem to be widely distributed. Since these have not been measured here,
it cannot be ascertained to what extent the changes reported are due to enzyme
and inhibitor content of the two types of tissue.
The differences in cytoplasmic distribution of the two DNAases point to the
presence of discrete enzymes. DNAase I was weak, and although the particles
contained less than the supernatant their specific activity was higher. DNAase II
was predominantly located in the supernatant, the specific activity of which
exceeded that of the particles. The distinction between the two RNAases was
less clear. Both were found predominatly in the supernatant, though the specific
activities of each were comparable in all cytoplasmic fractions. The widespread
occurrence of enzymes of both types (de Duve, Wattiaux and Baudhuin, 1962)
makes it probable that they are present also in cervix uteri.
Intracellular location of enzymes
The technical difficulties involved in this work necessitate caution in inter-
preting the distribution of nucleases in the material studied. Rupture of sub-
cellular particles can be expected as a consequence of storage and homogenisation
while losses into the nuclear pellet must have occurred during the first centrifuga-
tion. It was found that ultrasonic disintegration of the particles enhanced the
activity of all four nucleases, the time-interval of 90 seconds being the best
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compromise found on pilot experiments though not ideal for any of the four.
This increases the likelihood that the particles obtained possessed considerable
integrity. While it is probable that microsomes remained in the supernatant
after the final centrifugation, experiments using the M.S.E. Superspeed "40"
Preparative Ultracentrifuge showed that not more than 7-5% of the protein and
enzyme content ofthe supernatant could be precipitated by further centrifugatiorn
at 105,000 g for one hour.
The present results suggest that nucleases are present in all components of the
cytoplasm in the human cervix and predominate in the supernatant by virtue of
the higher protein content of this fraction. It seems unlikely that a single locus
can be assigned to any of the nucleases studied. Escape of enzyme from particles
could hardly give rise to specific activity in the supernatant which approaches and
exceeds that of the particles themselves, unless the organelles were present in
small numbers in mitochondrial and microsomal preparations. This kind of
distribution could arise ifthe enzymes were confined within lysosomes. Such was
at one time thought to be the case in rat liver (de Duve, Pressman, Gianetto,
Wattiaux and Appelmans, 1955; Reid and Nodes, 1959), but further work has
shown that significant amounts of acid RNAase are found in the cell sap of this
tissue (Reid and Nodes, 1963). Acid RNAase has also been found in the super-
natant of rat spleen (Eichel and Roth, 1962) and rat kidney (Reid and Stevens,
1958; de Lamirande and Allard, 1959a), while the microsomes of various tissues
undoubtedly contain various RNAases (Dickman and Morrill, 1959; Morris and
Dickman, 1960; Roth, 1960; Martin, England, Turkington and Leslie, 1963;
Morais and de Lamirande, 1965). Likewise, although de Duve et al. (1955)
considered DNAase II to be lysosomal, others have reported that activity is
largely divided between mitochondria and supernatant in rat liver (de Lamirande,
Allard, da Costa and Cantero, 1954) and rat spleen (Roth and Hilton, 1963), while
significant activity was found in the supernatant of rat kidney (Reid and Stevens,
1958). DNAase I appeared to be more concentrated in the particles than the
other nucleases. This accords with results of many investigations pointing to
mitochondria as the main locus of this enzyme in animal cells (Goutier-Pirotte and
0th, 1956; Dounce, O'Connell and Monty, 1957; Baudhuin, 1959).
Differences between normal and malignant cervix uteri
The cancer tissue seems to contain more cytoplasmic protein than normal
tissue, and a higher percentage of this protein is present in mitochondria and
microsomes. The activity of all the enzymes studied was greater in the cancer
tissue, and this statement holds true for the particle fractions as well as for the
supernatant. Some of these differences can be partly attributed to the content of
sub-epithelial stroma in the normal samples. This fibrous material seemed to
escape disruption during homogenisation and is unlikely to have contributed
protein or enzymes to the fractions analysed in amounts that would invalidate the
results obtained. The extent of this contribution can be roughly calculated from
the fact that the protein content of the supernatant per g of tissue in the normal
samples was only half that of the carcinomata. If we assume that fibrous conta-
mination in the carcinomata was negligible, we can hazard a guess that in normal
samples, epithelium was contaminated with no more than its own weight of
fibrous tissue. This would be insufficient to account for the large differences in
enzyme activity (three-fold to fifteen-fold) between cancers and normals.
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The specimens described as "normal" showed, in several instances, changes
such as epithelialisation, proliferation of secretory glands, and inflammatory
infiltration. This in no way invalidates the decision to regard them as "normal"
for comparative purposes. In human skin, which functionally and histologically
resembles the surface tissue of the cervix uteri,,nucleic-acid splitting enzymes are
present in the epidermis and not in the dermis (Santoianni and Rothman, 1961).
Lesions such as psoriasis which are associated with increased keratinisation are
accompanied by increased nuclease activity (Steigleder and Raab, 1962; Liss and
Lever, 1962). This implies that bias introduced by the use ofthese tissues would
lie in the direction of increased nuclease activity.
The differences between normal and cancerous cervix are in some instances so
great as to suggest diagnostic possibilities. With the two RNAases, separation
of the two groups is well-nigh complete. Since the activity at pH 7.4 is greater
than at pH 5.6, the former would be the estimation of choice emerging from the
present work. As most of the enzyme is found in the supernatant, it should be
worthy of investigation in vaginal fluid. Several studies of this material have
been reported, involving 8-glucuronidase (Odell and Burt, 1950; Lawson, 1959)
c-mannosidase (Lawson, 1960) and 6-phosphogluconate dehydrogenase (Bonham
and Gibbs, 1962). So far, none has proved sufficiently reliable to be ofroutine use.
Finally, it may be stated that the results obtained in this work suggest that the
changes involved in malignant transformation of the cervix uteri are different
from those occurring in other tissues, especially rat liver. Whereas malignancy
in this and other experimental animal tumours is associated with diminution of
mitochondria and endoplasmic reticulum (Allard, de Lamirande and Cantero,
1953; Fiala, 1953; Schneider et al., 1953; de Lamirande and Allard, 1959a;
Fiala and Fiala, 1959; Fiala, 1961), this does not appear to be the case with
cervix uteri. This conclusion is supported by an electron-microscope study which
showed that cancerous cervix had many more mitochondria per cell than normal
cervical tissue (Luibel, Sanders and Ashworth, 1960). The differences between
the present results and those outlined in the "Introduction" need not be
emphasised in detail. It is sufficient to counsel caution in the extrapolation of
findings from animal tumours to human tumours, and to stress the need for more
studies in the biochemistry of human neoplasms.
SUMMARY
The activities ofalkaline and acid ribonuclease (RNAase), deoxyribonuclease I
(DNAase I), DNAase II, and adenosine deaminase (ADase), were estimated in
cytoplasmic fractions prepared from malignant and non-malignant human cervix
uteri.
The activities of all five enzymes in the supernatant fraction of cancer speci-
mens greatly exceeded those ofnon-malignant samples relative to protein content
and tissue weight, the increase being most marked with the RNAases and least
pronounced for ADase.
No significant difference in nuclease activity was noted between the mito-
chondrial and microsomal fractions ofeither malignant or non-malignant samples,
but the activities of all except DNAase I were greatly increased in the particulate
fractions of malignant as compared with non-malignant cervix. The specific
activities of the nucleases relative to protein in the particulate fractions of both
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types of tissue were similar to those of the corresponding supernatant, except for
DNAase I which was more active in the particles.
The cytoplasmic protein content ofthe malignant samples exceeded that ofthe
non-malignant samples. This increase was proportionately much greater in the
particle fractions, so- that a higher percentage ofthe total cytoplasmic protein and
nuclease activities was present in these fractions in the cancers.
We should like to express our appreciation to Dr. Mary Cowell and Dr. J.
MacVicar who provided the majority of the specimens upon which this report is
based. Our thanks are also due to Dr. E. B. Hendry who allowed generous
facilities for this work, Professor D. F. Cappell who permitted the use ofequipment
within his department, and Professor J. N. Davidson, F.R.S. and Dr. R. Y.
Thomson for their advice and guidance.
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